dengue
Engineered Antibody Neutralizes All Four Dengue Serotypes
Researchers have designed an antibody that targets all four serotypes of dengue, sparking hopes for the first viable dengue therapeutic.
South Asia’s Dengue & Chikugunya Burden Much Higher Than Expected
Although 93 percent of the people tested had been previously infected, only one percent was aware that they had been ill from dengue.
Antibody That Targets DENV-2 Found
Unlike other DENV-2 binding antibodies, 2D22 is able to kill DENV-2 viruses of all morphologies.
The Sting In Dengue’s Tail
Three mutations in the tail of the dengue virus genome have been linked to the emergence of epidemics.
Dengue Day 2015: Interview With Professor Tikki Pang
From the perspective of a policymaker, implementation and operational research on dengue is far more urgent than basic research, says Professor Tikki Pang.
Dengue Day 2015: Interview With Dr. Joselito Sta. Ana
Sanofi Pasteur is currently the frontrunner in the dengue vaccine race. Joselito Sta. Ana, senior director of Sanofi Pasteur Asia Pacific gives us an update on their plans in Asia.
Dengue Day 2015: Top Dengue Stories On Asian Scientist
Want to catch up on the latest happenings in dengue research over the past year? Look no further!
Visterra & A*STAR To Bring Dengue Antibody To Clinical Trials
A*STAR's D3 has joined Visterra to bring the dengue monoclonal antibody VIS513 to proof-of-concept clinical trials.
Putting Patients First
What is an academic research organization and how does it benefit patients? We speak to Dr. Teoh Yee Leong, CEO of the Singapore Clinical Research Institute to find out more.
